Form 13G PROCEPT BioRobotics Corp For: 30 April
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Procept Biorobotics Corp (PRCT)
The Procept Biorobotics share price today is 24.63, view NASDAQ PRCT stock exchange data. Track the latest Procept Biorobotics share price with real-time updates on PRCT stock performance including market cap, day range, 52-week range and dividend yield. Access PRCT charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.16
24.99
52 wk Range
19.35
66.85
PRCT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.1624.99
52 wk Range
19.3566.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PRCT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
30.33
Upside
+23.16%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
7 Buy
4 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 30.33
(+23.16% Upside)
Procept Biorobotics Corp Earnings Call Summary for Q1/2026
- Procept Biorobotics Q1 2026 EPS of $0.56 beat forecast of -$0.56 by 200%; revenue reached $83.13M, up 20% YoY, exceeding $80.5M estimate.
- Gross margin improved to 65% from 64% YoY, though net loss widened to $31.6M from $24.7M as operating expenses rose to $86.6M from $71.6M.
- U.S. revenue grew 19% while international markets expanded 25%, driven by organizational realignment and pricing discipline initiatives.
- Stock declined 5.73% to $23.03 despite earnings beat; guidance projects negative EPS of -$1.55 for FY2026, weighing on investor sentiment.
- Eight analysts revised earnings downward; executives emphasized commitment to operational excellence and long-term growth despite near-term profitability challenges.
Last Updated: 30-04-2026, 03:18 am
Read Full TranscriptEarnings
Latest Release
29-04-2026
EPS / Forecast
0.56 / -0.56
Revenue / Forecast
83.13M / 80.5M
Compare PRCT to Peers and Sector
Metrics to compare | PRCT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPRCTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.7x | −1.2x | −0.5x | |
PEG Ratio | 1.69 | −0.03 | 0.00 | |
Price/Book | 4.0x | 6.2x | 2.6x | |
Price / LTM Sales | 4.4x | 5.7x | 3.2x | |
Upside (Analyst Target) | 29.0% | 56.0% | 47.8% | |
Fair Value Upside | Unlock | 3.3% | 6.7% | Unlock |
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Procept Biorobotics (PRCT) Share Price Today?
The Procept Biorobotics share price today is 24.63.
What is the current Procept Biorobotics (PRCT) share price and day range?
As of 02-05-2026, the Procept Biorobotics share price is 24.63, with a previous close of 24.04. The share price has ranged from 23.16 to 24.99 today, while the 52-week range spans from 19.35 to 66.85.
What Is the Procept Biorobotics Market Cap?
As of today, Procept Biorobotics market cap is 1.37B.
What Is the Procept Biorobotics (PRCT) Share Price Target?
The average 12-month share price target for Procept Biorobotics is 30.33, with a high estimate of 37 and a low estimate of 20. 7 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +23.16% Upside potential.
What Is Procept Biorobotics's Earnings Per Share (TTM)?
The Procept Biorobotics EPS (TTM) is -1.83.
When Is the Next Procept Biorobotics Earnings Date?
Procept Biorobotics will release its next earnings report on 30-07-2026.
From a Technical Analysis Perspective, Is PRCT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Procept Biorobotics Trade On?
Procept Biorobotics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Procept Biorobotics?
The stock symbol for Procept Biorobotics is "PRCT."
How Many Times Has Procept Biorobotics Stock Split?
Procept Biorobotics has split 0 times.
How Many Employees Does Procept Biorobotics Have?
Procept Biorobotics has 888 employees.
What Is the PRCT Premarket Price?
PRCT's last pre-market stock price is 24.50. The pre-market share volume is 3,690.00, and the stock has changed by 0.46, or 1.91%.
What Is the PRCT After Hours Price?
PRCT's last after hours stock price is 24.85, the stock has changed by 0.22, or 0.89%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.